6,8-difluoro-4-methylumbelliferyl phosphate: a fluorescent substrate of protein phosphatases 1 and 2A [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 2786976 |
| CHEBI ID | 133848 |
| SCHEMBL ID | 329996 |
| MeSH ID | M0305454 |
| Synonym |
|---|
| 214491-43-7 |
| 6,8-difluoro-4-methylumbelliferyl phosphate |
| CHEBI:133848 |
| (6,8-difluoro-4-methyl-2-oxochromen-7-yl) dihydrogen phosphate |
| SCHEMBL329996 |
| [(6,8-difluoro-4-methyl-2-oxo-2h-chromen-7-yl)oxy]phosphonic acid |
| bdbm13432 |
| difmup |
| 6,8-difluoro-4-methyl-umbelliferyl phosphate |
| 6,8-difluoro-4-methyl-2-oxo-2h-chromen-7-yl dihydrogen phosphate |
| DTXSID101261252 |
| 6,8-difluoro-4-methyl-7-(phosphonooxy)-2h-1-benzopyran-2-one |
| HY-120166 |
| 6,8-difluoro-4-methyl-2-oxo-2h-chromen-7-yldihydrogenphosphate |
| CS-0077049 |
| AKOS040751567 |
| Class | Description |
|---|---|
| coumarins | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (7.14%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (92.86%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| hymecromone | [no description available] | medium | 14 | 0 | hydroxycoumarin | antineoplastic agent; hyaluronic acid synthesis inhibitor |
| vanadates | [no description available] | medium | 1 | 0 | trivalent inorganic anion; vanadium oxoanion | EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor |
| hydrogen sulfide | [no description available] | medium | 1 | 0 | gas molecular entity; hydracid; mononuclear parent hydride; sulfur hydride | Escherichia coli metabolite; genotoxin; metabolite; signalling molecule; toxin; vasodilator agent |
| cysteine | [no description available] | medium | 1 | 0 | cysteinium | fundamental metabolite |
| thiocyanate | [no description available] | medium | 1 | 0 | pseudohalide anion; sulfur molecular entity | human metabolite |
| sodium sulfide | [no description available] | medium | 1 | 0 | ||
| calyculin a | [no description available] | medium | 1 | 0 | ||
| oxazoles | [no description available] | medium | 1 | 0 | 1,3-oxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene | |
| 4-methylumbelliferyl phosphate | [no description available] | medium | 2 | 0 | ||
| 4-nitrophenylphosphate | [no description available] | medium | 2 | 0 | aryl phosphate | mouse metabolite |
| cyanoginosin lr | [no description available] | medium | 2 | 0 | microcystin | bacterial metabolite; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; environmental contaminant; xenobiotic |
| nitrophenols | [no description available] | medium | 2 | 0 | ||
| erythrosine | [no description available] | medium | 1 | 0 | ||
| acid phosphatase | [no description available] | medium | 1 | 0 | ||
| coumarin | [no description available] | low | 0 | 0 | coumarins | fluorescent dye; human metabolite; plant metabolite |
| 4-methylumbelliferyl acetate | [no description available] | low | 0 | 0 | acetate ester; coumarins | plant metabolite |
| 5,7-dimethoxycoumarin | [no description available] | low | 0 | 0 | coumarins | |
| 6-methylcoumarin | [no description available] | low | 0 | 0 | coumarins | allergen; fragrance |
| scoparone | [no description available] | low | 0 | 0 | aromatic ether; coumarins | anti-allergic agent; anti-inflammatory agent; antihypertensive agent; antilipemic drug; immunosuppressive agent; plant metabolite |
| osthol | [no description available] | low | 0 | 0 | botanical anti-fungal agent; coumarins | metabolite |
| cyclocumarol | [no description available] | low | 0 | 0 | coumarins | |
| herniarin | [no description available] | low | 0 | 0 | coumarins | fluorochrome |
| coumarin-3-carboxylic acid | [no description available] | low | 0 | 0 | coumarins | |
| chromonar | [no description available] | low | 0 | 0 | coumarins | |
| 7-methylcoumarin | [no description available] | low | 0 | 0 | coumarins | |
| 7-ethoxycoumarin | [no description available] | low | 0 | 0 | aromatic ether; coumarins | |
| xanthyletine | [no description available] | low | 0 | 0 | coumarins | |
| xanthoxyletin | [no description available] | low | 0 | 0 | coumarins | metabolite |
| 4-methyl-7-ethoxycoumarin | [no description available] | low | 0 | 0 | coumarins | |
| seselin | [no description available] | low | 0 | 0 | coumarins | metabolite |
| suberosin | [no description available] | low | 0 | 0 | aromatic ether; coumarins | anticoagulant; plant metabolite |
| cloricromen | [no description available] | low | 0 | 0 | coumarins | |
| 3-acetylcoumarin | [no description available] | low | 0 | 0 | coumarins | |
| 4-methylumbelliferyl sulfate | [no description available] | low | 0 | 0 | aryl sulfate; coumarins | human xenobiotic metabolite |
| 4-methylumbelliferyl butyrate | [no description available] | low | 0 | 0 | butyrate ester; coumarins | chromogenic compound |
| 7-(diethylamino)-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 4-methylumbelliferyl glucuronide | [no description available] | low | 0 | 0 | beta-D-glucosiduronic acid; coumarins; monosaccharide derivative | antineoplastic agent; chromogenic compound; hyaluronan synthesis inhibitor |
| 4-methylumbelliferyl-galactopyranoside | [no description available] | low | 0 | 0 | beta-D-galactoside; coumarins; monosaccharide derivative | chromogenic compound |
| skimmin | [no description available] | low | 0 | 0 | coumarins; glycoside | |
| n-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide | [no description available] | low | 0 | 0 | benzenes; coumarins; maleimides; tertiary amino compound | fluorescent dye |
| 4-methylumbelliferylcellobioside | [no description available] | low | 0 | 0 | coumarins; glycoside | |
| N-(2-oxo-1-benzopyran-3-yl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
| bucumolol | [no description available] | low | 0 | 0 | coumarins | |
| 3-chloro-7-methoxy-4-methyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| khellactone | [no description available] | low | 0 | 0 | coumarins | |
| dentatin | [no description available] | low | 0 | 0 | coumarins | metabolite |
| rosiglitazone | [no description available] | low | 0 | 0 | acetate ester; coumarins; diester | pro-angiogenic agent; radical scavenger |
| 5,7-dimethoxy-4-methyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 7-methoxy-4-methyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| scopolin | [no description available] | low | 0 | 0 | beta-D-glucoside; coumarins; monosaccharide derivative | plant metabolite |
| decursin | [no description available] | low | 0 | 0 | coumarins | |
| visnadin | [no description available] | low | 0 | 0 | coumarins | |
| glycyrin | [no description available] | low | 0 | 0 | aromatic ether; coumarins; hydroxyisoflavans | antibacterial agent; metabolite; plant metabolite |
| 6-methyl-4-(morpholinomethyl)-2H-chromen-2-one | [no description available] | low | 0 | 0 | coumarins | |
| lomatin | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(6-chloro-2-oxo-4-propyl-1-benzopyran-7-yl)oxy]-N,N-dimethylacetamide | [no description available] | low | 0 | 0 | coumarins | |
| 2-oxo-N-(2-pyridinylmethyl)-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
| N-[3-(4-morpholinyl)propyl]-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
| 8-methoxy-N-(6-methyl-2-pyridinyl)-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(6-chloro-4-ethyl-2-oxo-1-benzopyran-7-yl)oxy]propanoic acid | [no description available] | low | 0 | 0 | coumarins | |
| 4,8-dimethyl-3-(phenylmethyl)-7-(2H-tetrazol-5-ylmethoxy)-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 1-[1-oxo-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]ethyl]-4-piperidinecarboxylic acid | [no description available] | low | 0 | 0 | coumarins | |
| 3-[4,8-dimethyl-2-oxo-7-(2H-tetrazol-5-ylmethoxy)-1-benzopyran-3-yl]propanoic acid ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 3,4,7-trimethyl-5-(3-oxobutan-2-yloxy)-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 4,9-dimethyl-3-(2H-tetrazol-5-ylmethoxy)-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-6-one | [no description available] | low | 0 | 0 | coumarins | |
| 4-[(4-ethyl-1-piperazinyl)methyl]-5,7-dimethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 7-[(3,5-dimethyl-4-isoxazolyl)methoxy]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 7-(diethylamino)-2-oxo-1-benzopyran-3-carbonitrile | [no description available] | low | 0 | 0 | coumarins | |
| 2-oxo-N-(3-pyridinylmethyl)-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-1-yl)oxy]acetic acid propan-2-yl ester | [no description available] | low | 0 | 0 | coumarins; isopropyl ester | |
| 5-methyl-4-[(2-oxo-1-benzopyran-7-yl)oxymethyl]-2-furancarboxylic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 6-methoxy-2-oxo-N-(3-pyridinylmethyl)-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
| (4-Methyl-2-oxochromen-7-yl) furan-2-carboxylate | [no description available] | low | 0 | 0 | coumarins | anticoronaviral agent |
| 2-furancarboxylic acid (7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-9-yl) ester | [no description available] | low | 0 | 0 | coumarins | |
| N-(4-amino-2-oxo-1-benzopyran-3-yl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
| 3-(8-methyl-2-imidazo[1,2-a]pyridinyl)-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| (4-Ethyl-2-oxochromen-7-yl) furan-2-carboxylate | [no description available] | low | 0 | 0 | coumarins | anticoronaviral agent |
| 5-(3,3-dimethyl-2-oxobutoxy)-4-ethyl-7-methyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 7-methoxy-4,8-dimethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 8-chloro-7-propan-2-yloxy-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-4-one | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(3-ethyl-4-methyl-2-oxo-1-benzopyran-7-yl)oxy]acetic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 7-methoxy-2-oxo-1-benzopyran-3-carboxylic acid ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 2-(2,3-dimethylphenoxy)-N-(2-oxo-1-benzopyran-6-yl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
| 1-(4-methyl-2-oxo-1-benzopyran-7-yl)-3-(2-pyridinylmethyl)thiourea | [no description available] | low | 0 | 0 | coumarins | |
| 8-methoxy-N-methyl-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
| 4-methyl-6-[2-(4-methyl-1-piperidinyl)-2-oxoethoxy]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 3-[(4-benzoyl-1-piperazinyl)-oxomethyl]-8-methoxy-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 3-[(4-nitrophenyl)methoxy]-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-6-one | [no description available] | low | 0 | 0 | coumarins | |
| 3-[2-(4-aminoanilino)-4-thiazolyl]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(4-methyl-2-oxo-1-benzopyran-7-yl)oxy]-N-(5-propan-2-yl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
| 3-[oxo-[4-(2-phenylethyl)-1-piperazinyl]methyl]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 6-bromo-N-[2-(dimethylamino)ethyl]-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
| 8-methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| N-cyclohexyl-2-[(8-methoxy-6-oxo-3-benzo[c][1]benzopyranyl)oxy]acetamide | [no description available] | low | 0 | 0 | coumarins | |
| 5-methyl-4-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-1-yl)oxymethyl]-2-furancarboxylic acid | [no description available] | low | 0 | 0 | coumarins | |
| 5-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-1-yl)oxymethyl]-2-furancarboxylic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 4-methyl-3-(phenylmethyl)-7-[(3,4,5-trimethoxyphenyl)methoxy]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 5-(3,3-dimethyl-2-oxobutoxy)-3,4,7-trimethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| Methyl 7-methoxycoumarin-4-acetate | [no description available] | low | 0 | 0 | coumarins | |
| aurapten | [no description available] | low | 0 | 0 | coumarins; monoterpenoid | antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; dopaminergic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; gamma-secretase modulator; gastrointestinal drug; hepatoprotective agent; matrix metalloproteinase inhibitor; neuroprotective agent; plant metabolite; PPARalpha agonist; vulnerary |
| 2-[(7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-9-yl)oxy]acetic acid butyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 4-(4-methylphenyl)-2-[[oxo-(2-oxo-1-benzopyran-3-yl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 5-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxymethyl]-2-furancarboxylic acid | [no description available] | low | 0 | 0 | coumarins | |
| 6-methyl-7-[2-nitro-4-(trifluoromethyl)phenoxy]-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-4-one | [no description available] | low | 0 | 0 | coumarins | |
| 3-methoxy-N-[[(2-oxo-1-benzopyran-6-yl)amino]-sulfanylidenemethyl]benzamide | [no description available] | low | 0 | 0 | coumarins | |
| 3-acetyl-7-methoxycoumarin | [no description available] | low | 0 | 0 | coumarins | |
| acetic acid 2-[[oxo-(2-oxo-1-benzopyran-3-yl)methyl]amino]ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 4-(2,3-dihydroindol-1-ylmethyl)-7-ethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 3-[4-[(4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methyl]-3-(2-oxo-1-benzopyran-3-yl)-1-pyrazolyl]propanoic acid | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-2-yl)oxy]acetic acid ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 1-[oxo-(2-oxo-1-benzopyran-3-yl)methyl]-4-piperidinecarboxylic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(3,4-dimethyl-2-oxo-1-benzopyran-7-yl)oxy]acetic acid prop-2-enyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(3,4,8-trimethyl-2-oxo-1-benzopyran-7-yl)oxy]acetic acid prop-2-enyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 1-(2-hydroxyethyl)-4-[1]benzopyrano[3,4-d]triazolone | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(4-methyl-2-oxo-1-benzopyran-7-yl)oxy]-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
| 4-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]-7-ethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| N-cyclohexyl-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]acetamide | [no description available] | low | 0 | 0 | coumarins | |
| 3-bromo-N-(4-methyl-2-oxo-1-benzopyran-7-yl)benzamide | [no description available] | low | 0 | 0 | coumarins | |
| 3-[ethyl(phenyl)sulfamoyl]-4-methylbenzoic acid (4-methyl-2-oxo-1-benzopyran-7-yl) ester | [no description available] | low | 0 | 0 | coumarins | |
| aflatoxin g2 | [no description available] | low | 0 | 0 | coumarins | |
| 4-methylumbelliferyl glucoside | [no description available] | low | 0 | 0 | beta-D-glucoside; coumarins; monosaccharide derivative | chromogenic compound |
| 2,3-dihydro-2,3-dihydroxyaflatoxin b(1) | [no description available] | low | 0 | 0 | coumarins | |
| 6,7,8-trimethoxycoumarin | [no description available] | low | 0 | 0 | coumarins | |
| 3-O-Acetylepisamarcandin | [no description available] | low | 0 | 0 | coumarins | |
| conferone | [no description available] | low | 0 | 0 | coumarins | |
| 2-[(2-ethyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-3-yl)oxy]acetic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
| N-[2-(1-cyclohexenyl)ethyl]-2-(4-oxo-1-[1]benzopyrano[4,3-c]pyrazolyl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
| 3-pyridinecarboxylic acid 2-[[oxo-(2-oxo-1-benzopyran-3-yl)methyl]amino]ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
| N-(3-methoxypropyl)-2-(4-oxo-1-[1]benzopyrano[4,3-c]pyrazolyl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
| 7-[[5-(4-methoxyphenyl)-4-thieno[2,3-d]pyrimidinyl]oxy]-4-methyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins; thienopyrimidine | |
| N-(2-oxo-1-benzopyran-3-yl)cyclohexanecarboxamide | [no description available] | low | 0 | 0 | coumarins | |
| 4-[(4-chlorophenyl)methylamino]-3-nitro-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 2-(3-oxo-4H-1,4-benzothiazin-2-yl)acetic acid (7-methoxy-2-oxo-1-benzopyran-4-yl)methyl ester | [no description available] | low | 0 | 0 | coumarins | |
| 2-(3-oxo-4H-1,4-benzothiazin-2-yl)acetic acid (7-acetamido-2-oxo-1-benzopyran-4-yl)methyl ester | [no description available] | low | 0 | 0 | coumarins | |
| Meranzin hydrate | [no description available] | low | 0 | 0 | coumarins | |
| N-(1,1-dioxo-3-thiolanyl)-N-[(4-ethoxyphenyl)methyl]-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
| capillarisin | [no description available] | low | 0 | 0 | coumarins | |
| pteryxin | [no description available] | low | 0 | 0 | coumarins | |
| 4-[1-[(4-methyl-2-oxo-1-benzopyran-7-yl)amino]-3-oxo-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
| glycycoumarin | [no description available] | low | 0 | 0 | aromatic ether; coumarins; resorcinols | antispasmodic drug; plant metabolite |
| phebalosin | [no description available] | low | 0 | 0 | coumarins | |
| urolithin b | [no description available] | low | 0 | 0 | coumarins | |
| 7-hydroxy-6-(4-morpholinylmethyl)-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-4-one | [no description available] | low | 0 | 0 | coumarins | |
| 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one | [no description available] | low | 0 | 0 | coumarins | geroprotector |
| N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-8-methyl-4-oxo-2-thieno[3,2-c][1]benzopyrancarboxamide | [no description available] | low | 0 | 0 | coumarins | |
| N-ethyl-8-methyl-4-oxo-N-(phenylmethyl)-2-thieno[3,2-c][1]benzopyrancarboxamide | [no description available] | low | 0 | 0 | coumarins | |
| trichodermamide a | [no description available] | low | 0 | 0 | coumarins | |
| 3-hydroxy-3-methyl-5-oxo-5-[[3,4,5-trihydroxy-6-[[6-methoxy-2-oxo-3-[(2-oxo-1-benzopyran-7-yl)oxy]-1-benzopyran-7-yl]oxy]-2-oxanyl]methoxy]pentanoic acid | [no description available] | low | 0 | 0 | coumarins; glycoside | |
| auraptenol | [no description available] | low | 0 | 0 | coumarins | |
| foetidin | [no description available] | low | 0 | 0 | coumarins | |
| ro5126766 | [no description available] | low | 0 | 0 | aryloxypyrimidine; coumarins; organofluorine compound; pyridines; sulfamides | antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
| 8-[1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)propyl]-5,7-dimethoxy-4-pentyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 5,7-dimethoxy-4-methyl-8-[3-(4-morpholinyl)-1-(3,4,5-trimethoxyphenyl)propyl]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| 8-{1-[4-(dimethylamino)phenyl]-3-(pyrrolidin-1-yl)propyl}-5,7-dimethoxy-4-pentyl-2H-chromen-2-one | [no description available] | low | 0 | 0 | aromatic ether; coumarins; pyrrolidines; tertiary amino compound | |
| 8-[3-(diethylamino)-1-(4-methoxyphenyl)propyl]-5,7-dimethoxy-4-pentyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
| coumermycin | [no description available] | low | 0 | 0 | aromatic amide; coumarins; glycoside; heteroarenecarboxylate ester; pyrroles | antimicrobial agent; antineoplastic agent; bacterial metabolite; DNA synthesis inhibitor; Hsp90 inhibitor; topoisomerase IV inhibitor |
| urolithin c | [no description available] | low | 0 | 0 | coumarins |
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| Sensitivity and Specificity | 0 | low | 4 | 0 |